Tracking blood thinner safety: can patients stick with their meds?
NCT ID NCT07458191
Summary
This study aims to monitor the safety and real-world use of the blood thinner apixaban in patients with atrial fibrillation, a heart condition that increases stroke risk. Researchers will follow 800 patients for six months to see how often serious bleeding or other side effects occur and to check if patients are taking their medication as prescribed. The goal is to better understand the risks and benefits of this common preventive treatment in everyday practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONVALVULAR ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinic for diseases of the heart, blood vessels and rheumatism
RECRUITINGSarajevo, 71000, Bosnia and Herzegovina
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.